Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries

201977 citationsJournal Articlegreen Open Access

Authors

C.M. Lanier · Wake Forest University

Ryan T. Hughes · Wake Forest University

Tamjeed Ahmed · Wake Forest University

M.C. LeCompte · Wake Forest University

Adrianna Masters · Wake Forest University

W. Jeffrey Petty · Wake Forest University

Jimmy Ruiz ·

Abstract

The use of immunotherapy in patients with lung cancer or melanoma metastatic to the brain treated with SRS is associated with improved OS and decreased incidence of neurologic death.

Topics & Keywords

Brain Metastases and Treatment Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Neuro-Oncology Practice

Volume 6, Issue 5, pp. 402-409

DOI: 10.1093/nop/npz004

Field-Weighted Citation Impact: 8.30